Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cuzick

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
British Journal of Cancer|June 4, 2014
Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trialI Juraskova, P Butow, C Bonner, et al.
British Journal of Cancer|February 2, 2013
Comparing the performance of six human papillomavirus tests in a screening populationJ Cuzick, L Cadman, D Mesher, et al.
Lancet (London, England)|January 11, 2005
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancerA Howell, J Cuzick, M Baum, et al.
British Journal of Cancer|March 6, 2014
Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinicL S Donnelly, D G Evans, J Wiseman, et al.
British Journal of Cancer|November 2, 2006
Long-term outcome among men with conservatively treated localised prostate cancerJ Cuzick, G Fisher, M W Kattan, et al.
Lancet (London, England)|August 26, 1998
Electropotential measurements as a new diagnostic modality for breast cancerJ Cuzick, R Holland, V Barth, et al.
BMJ (Clinical Research Ed.)|June 2, 2000
Single blind, randomised trial of efficacy and acceptability of oral picolax versus self administered phosphate enema in bowel preparation for flexible sigmoidoscopy screeningW S Atkin, A Hart, R Edwards, et al.
British Journal of Cancer|July 2, 1999
Mutation testing in melanoma families: INK4A, CDK4 and INK4DJ A Newton Bishop, M Harland, D C Bennett, et al.
British Journal of Cancer|January 17, 2013
Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancerI Ahmad, L B Singh, Z H Yang, et al.
Histopathology|September 21, 2007
Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcomeD M Berney, G Fisher, M W Kattan, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
British Journal of Cancer|June 4, 2014
Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trialI Juraskova, P Butow, C Bonner, et al.
British Journal of Cancer|February 2, 2013
Comparing the performance of six human papillomavirus tests in a screening populationJ Cuzick, L Cadman, D Mesher, et al.
Lancet (London, England)|January 11, 2005
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancerA Howell, J Cuzick, M Baum, et al.
British Journal of Cancer|March 6, 2014
Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinicL S Donnelly, D G Evans, J Wiseman, et al.
British Journal of Cancer|November 2, 2006
Long-term outcome among men with conservatively treated localised prostate cancerJ Cuzick, G Fisher, M W Kattan, et al.
Lancet (London, England)|August 26, 1998
Electropotential measurements as a new diagnostic modality for breast cancerJ Cuzick, R Holland, V Barth, et al.
BMJ (Clinical Research Ed.)|June 2, 2000
Single blind, randomised trial of efficacy and acceptability of oral picolax versus self administered phosphate enema in bowel preparation for flexible sigmoidoscopy screeningW S Atkin, A Hart, R Edwards, et al.
British Journal of Cancer|July 2, 1999
Mutation testing in melanoma families: INK4A, CDK4 and INK4DJ A Newton Bishop, M Harland, D C Bennett, et al.
British Journal of Cancer|January 17, 2013
Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancerI Ahmad, L B Singh, Z H Yang, et al.
Histopathology|September 21, 2007
Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcomeD M Berney, G Fisher, M W Kattan, et al.
Pageof 23